Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Trav7d-2 Inhibitors

Trav7d-2 inhibitors represent a specific chemical class designed to interact with and modulate the activity of the Trav7d-2 protein or receptor, which is likely part of a larger biochemical pathway. These inhibitors are typically characterized by their ability to bind to the active or regulatory sites of the Trav7d-2 target, preventing its normal biological function. The chemical structure of Trav7d-2 inhibitors can vary widely, but they usually possess key functional groups that allow for strong interactions, such as hydrogen bonding, hydrophobic interactions, or ionic bonding with the Trav7d-2 binding site. These interactions are crucial in defining the specificity and potency of the inhibitor. Depending on the nature of the Trav7d-2 protein, inhibitors may either directly compete with a natural substrate or modulate its activity through allosteric mechanisms, which involve binding at sites other than the active site.

From a chemical perspective, Trav7d-2 inhibitors may exhibit diverse structural frameworks, including small molecules, peptides, or larger biomolecules, depending on the design and the requirements for binding specificity. Structural features such as aromatic rings, heteroatoms (e.g., nitrogen, oxygen, or sulfur), and charged moieties often play key roles in stabilizing the interaction between the inhibitor and Trav7d-2. In addition, these inhibitors may be designed to optimize solubility, stability, and permeability based on the chemical environment in which they must function. Understanding the precise chemical properties of Trav7d-2 inhibitors, such as their lipophilicity, molecular weight, and polar surface area, is essential in evaluating how effectively they can interact with the Trav7d-2 target, providing insights into their biochemical impact.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$62.00
$90.00
$299.00
$475.00
$1015.00
$2099.00
69
(5)

Cyclosporin A may inhibit T cell receptor alpha variable 7D-2 expression by blocking calcineurin, a key phosphatase involved in T cell receptor signaling and gene transcription.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Sirolimus may inhibit T cell receptor alpha variable 7D-2 expression by binding to FKBP12 and inhibiting mTOR, a central regulator of T cell activation and proliferation pathways.

FK-506

104987-11-3sc-24649
sc-24649A
5 mg
10 mg
$76.00
$148.00
9
(1)

Tacrolimus may inhibit T cell receptor alpha variable 7D-2 expression by binding to FK506-binding protein 12, leading to inhibition of calcineurin and downstream T cell activation.

Mycophenolic acid

24280-93-1sc-200110
sc-200110A
100 mg
500 mg
$68.00
$261.00
8
(1)

Mycophenolic acid may inhibit T cell receptor alpha variable 7D-2 expression by inhibiting inosine monophosphate dehydrogenase, an enzyme essential for de novo guanosine synthesis.

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$128.00
$638.00
7
(1)

Everolimus may inhibit T cell receptor alpha variable 7D-2 expression by binding to FKBP12 and inhibiting mTOR, a central regulator of T cell activation and proliferation pathways.

FTY720

162359-56-0sc-202161
sc-202161A
sc-202161B
1 mg
5 mg
25 mg
$32.00
$75.00
$118.00
14
(1)

Fingolimod may inhibit T cell receptor alpha variable 7D-2 expression by modulating sphingosine-1-phosphate receptors, sequestering T cells in lymphoid organs and preventing activation.